U.S. federal trademark · Serial No. 90807080 · Reg. No. 03662804
Cell therapy pharmaceutical preparations; pharmaceutical immunotherapy preparations for use in cancer treatment; T-cell receptors in the nature of pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment
Cell therapy medical treatment services; medical immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.